Identification of novel large genomic rearrangements at the BRCA1 locus in Malaysian women with breast cancer

Cancer Epidemiology

Volumn 34, Issue 4, 2010, Pages 442-447

  Sharifah, Noor Akmal ^a   Nurismah, Md Isa ^a   Lee, Han Chung ^a   Aisyah, Aziz Nur ^a   Clarence Ko, Ching Huat ^a   Naqiyah, Ismail ^a   Rohaizak, Mohamad ^a   Fuad, Ismail ^a   A Jamal, A Rahman ^b   Zarina, Abdul Latiff ^b   Nor Aina, Emran ^c   Normayah, Kitan ^d   Nor Hisham, Abdullah ^d  

^a UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

^b UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^c HOSPITAL KUALA LUMPUR   (Malaysia)

^d PUTRAJAYA HOSPITAL   (Malaysia)

Author keywords

BRCA1; Large genomic rearrangements; Malaysia; MLPA; QPCR; Sporadic breast cancer

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; DNA;

ADULT; AGED; ARTICLE; BREAST CANCER; FEMALE; GENE IDENTIFICATION; GENE LOCUS; GENE REARRANGEMENT; HUMAN; MAJOR CLINICAL STUDY; MALAYSIA; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; BREAST TUMOR; CLINICAL TRIAL; COMPARATIVE STUDY; GENETIC SCREENING; GENETICS; GERMLINE MUTATION; HUMAN GENOME; MALE; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; SURVIVAL RATE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; DNA, NEOPLASM; FEMALE; GENE REARRANGEMENT; GENETIC TESTING; GENOME, HUMAN; GERM-LINE MUTATION; HUMANS; MALAYSIA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SURVIVAL RATE;

EID: 77955091928     PISSN: 18777821     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canep.2010.04.010     Document Type: Article

References (29)

1. Miki Y., Swensen J., Eidens S.D., Futreal P.A., Harshman K., Tavtigian S., et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994, 266:66-71.
2. Wooster R., Bignell G., Lancaster J., Swift S., Seal S., Mangion J., et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995, 378:789-792.
3. Ford D., Easton D.F., Stratton M., Narod S., Goldgar D., Devilee P., et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 1998, 62:676-689.
4. Balraj P., Khoo A.S.B., Volpi L., Tan J.A.M.A., Nair S., Abdullah H. Mutation analysis of the BRCA1 gene in Malaysian breast cancer patients. Singapore Med J 2002, 43(4):194-197.
5. Toh G.T., Kang P., Lee S.S.W., Lee D.S.C., Lee S.Y., Selamat S., et al. BRCA1 and BRCA2 germline mutations in Malaysian women with early-onset breast cancer without a family history. Plos One 2008, 3(4):e2024.
6. Thirthagiri E., Lee S.Y., Kang P., Lee D.S., Toh G.T., Selamat S., et al. Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer. Breast Cancer Research 2008, 10(4):R59.
7. Ewald I.P., Ribeiro P.L.I., Palmero E.I., Cossio S.L., Roberto Giugliani R., Ashton-Prolla P. Genomic rearrangements in BRCA1 and BRCA2: a literature review. Genet Mol Biol 2009, 32(3):437-446.
8. Montagna M., Palma M.D., Menin C., et al. Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families. Hum Mol Genet 2003, 12(9):1055-1061.
9. Hogervorst F.B., Nederlof P.M., Gille J.J., Agata S., Nicolo A.D., Chieco-Bianchi L., et al. Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. Cancer Res 2003, 63:1449-1453.
10. Karhu R., Laurila E., Kallioniemi A., Syrjakoski K. Large genomic BRCA2 rearrangements and male breast cancer. Cancer Detect Prev 2006, 30:530-534.
11. Yip C.H., Nur Aishah M.T., Ibraham M. Epidemiology of breast cancer in Malaysia. Asian Pacific J Cancer Prev 2006, 7:369-374.
12. Arnold N., Gross E., Schwarz-Boeger U., Pfisterer J., Jonat W., Kiechle M. A highly sensitive, fast, and economical technique for mutation analysis in hereditary breast and ovarian cancers. Hum Mutat 1999, 14:333-339.
13. Gross E., Arnold N., Pfisterer J., Bandick K., Kiechle M. Identification of specific BRCA1 and BRCA2 variants by DHPLC. Hum Mutat 2000, 16:345-353.
14. Barrois M., Bie'che I., Mazoyer S., Champe'me M.H., Bressac-de Paillere B., Lidereau R. Real-time PCR-based gene dosage assay for detecting BRCA1 rearrangements in breast-ovarian cancer families. Clin Genet 2004, 65:131-136.
15. Introduction to quantitative PCR: methods & applications guide 2007, Stratagene, pp. 37-43.
16. Sharifah N.A., Nurismah M.I., Lee H.C., Clarence-Ko C.H., Naqiyah I., Rohaizak M., et al. Denaturing high performance liquid chromatography (DHPLC) in the screening of BRCA1 and BRCA2 mutations in breast cancer. Proceedings of the 8th Malaysia Genetic Congress 2009.
17. Lim Y.K., Lau P.T.C., Ali A.B., Lee S.C., Wong J.E.-L., Putti T.C., et al. Identification of novel BRCA large genomic rearrangements in Singapore Asian breast and ovarian patients with cancer. Clin Genet 2007, 71:331-342.
18. Puget N., Torchard D., Serova-Sinilnikova O.M., Pages S., Lynch H.T., Lenoir G.M., et al. A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17. Can Res 1997, 57:828-831.
19. Petrij-Bosch A., Peelen T., van Vliet M., Eijk R.V., Olmer R., Drusedau M., et al. BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet 1997, 17:341-345.
20. Puget N., Stoppa-Lyonnet D., Sinilnikova O.M., Pages S., Lynch H.T., Lenoir G.M., et al. Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions. Cancer Res 1999, 59:455-461.
21. Swensen J., Hoffman M., Skolnick M.H., Neuhausen S.L. Identification of a 14kb deletion involving the promoter region of BRCA1 in a breast cancer family. Hum Mol Genet 1997, 6:1513-1517.
22. Rohlfs E.M., Puget N., Graham M.L., et al. An Alu-mediated 7.1kb deletion of BRCA1 exons 8 and 9 in breast and ovarian cancer families that results in alternative splicing of exon 10. Genes Chromosomes Cancer 2000, 28:300-307.
23. Hartmann C., John A.L., Klaes R., Hofmann W., Bielen R., Koehler R., et al. Large BRCA1 gene deletions are found in 3% of German high-risk breast cancer families. Hum Mutat 2004, 24(6):534.
24. Armaoua S., Konstantopouloub I., Anagnostopoulosa T., Razisc E., Boukovinasd L, Xenidisd N., et al. Novel genomic rearrangements in the BRCA1 gene detected in Greek breast/ovarian cancer patients. Eur J Cancer 2007, 43:443-453.
25. Welch P.L., King M.C. BRCA1 and BRCA2 and the genetic of breast and ovarian cancer. Hum Mol Genet 2001, 10(7):705-713.
26. Smith T.M., Lee M.K., Szabo C.I., Jerome N., McEuen M., Taylor M., et al. Complete genomic sequence and analysis of 117kb of human DNA containing the gene BRCAI. Genome Res 1997, 6:1029-1049.
27. Deininger P.L., Batzer M.A. Alu repeats and human disease. Mol Genet Metab 1999, 67:183-193.
28. Woodward A.M., Davis T.A., Silva A.G.S., kConFab Investigators, Kirk J.A., Leary JA Large genomic rearrangements of both BRCA2 and BRCA1 are a feature of the inherited breast/ovarian cancer phenotype in selected families. J. Med. Genet. 2005, 42:e31.
29. Tournier I., Bressac-de Paillerets B., Sobol H., Stoppa-Lyonnet O., Lidereau R., Barrois M., et al. Significant contribution of germline BRCA2 rearrangements in male breast cancer families. Cancer Res 2004, 64:8143-8147.